Clinical Trials Logo

Filter by:
NCT ID: NCT04599296 Completed - Clinical trials for Femoroacetabular Impingement Syndrome

Postoperative Hip Bracing After Hip Arthroscopy

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Hip arthroscopy for treatment of femoroacetabular impingement syndrome (FAIS) involves reshaping of the osseous sources of impingement ("osteoplasty") and treatment of impingement-associated labral tears with labral repair. Postoperative hip braces are advocated to decrease postoperative pain by offloading hip musculature. However there are no studies looking at efficacy of hip braces after hip arthroscopy, and on average 50% of high-volume hip arthroscopists use bracing. The objective of this study is to use a randomized controlled trial to test the cited benefits of postoperative hip bracing on short term patient reported pain scores, validated hip-specific pain scores, and physical exam findings of hip flexor tendonitis.

NCT ID: NCT04599283 Completed - Overactive Bladder Clinical Trials

BE Technologies Mobile Uroflowmetry Validation Study

Start date: August 18, 2020
Phase: N/A
Study type: Interventional

This research study is studying MenHealth Mobile Uroflowmetry as a diagnostic tool for LUTS (lower urinary tract symptoms), a group of conditions involving the bladder, urinary sphincter, urethra and the prostate.

NCT ID: NCT04599257 Completed - Fat Burn Clinical Trials

Fat Reduction and Muscle Toning of Thighs

Start date: September 15, 2020
Phase: N/A
Study type: Interventional

This study will evaluate the clinical efficacy and safety of a simultaneous application of high-intensity focused electromagnetic procedure and radiofrequency energy for changes in subcutaneous fat tissue and muscle toning of thighs.

NCT ID: NCT04599166 Completed - Clinical trials for Advance Care Planning

Choosing an Effective Healthcare Spokesperson: An Interactive Intervention

Start date: August 3, 2021
Phase: N/A
Study type: Interventional

The investigators developed a "serious game" intervention called "Who Would You Choose: Serious Fun" (WWYC) to help people consider the key qualities healthcare spokespersons should have. The intervention uses a spinner, cards, and dice, along with a smart-phone App to prompt players (using scenarios and metaphors) to choose a spokesperson whose qualities are best suited to the role. Friendly competition is encouraged by having players receive points for correct answers, and additional points for good explanations of their choices. At the end of the game, players identify a real-life spokesperson based on the qualities considered during game-play. Then, using an associated smart-phone App, the intervention will help spark communication between the player and their chosen spokesperson.

NCT ID: NCT04599075 Completed - Type 1 Diabetes Clinical Trials

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Start date: March 15, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to perform a randomized trial to investigate if intrapartum insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous insulin infusion with regard to the primary outcome of neonatal blood sugar.

NCT ID: NCT04598724 Completed - Clinical trials for Muscle-Invasive Bladder Carcinoma

Addressing Barriers to Palliative Care Use in Bladder Cancer

Start date: December 22, 2020
Phase:
Study type: Observational

Investigators plan to establish an in-depth understanding of knowledge and beliefs about palliative care in advanced Bladder Cancer patients and their caregivers, and to identify factors associated with positive and negative experiences with palliative care services among those who have received them.

NCT ID: NCT04598711 Completed - Cerebral Palsy Clinical Trials

Ischemic Conditioning to Enhance Function (I-C-FUN) in Children With Cerebral Palsy

I-C-FUN
Start date: June 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine if remote limb ischemic conditioning (RLIC) can increase skeletal muscle power, enhance learning of motor (dynamic balance) task, and improve walking performance in children with cerebral palsy (CP).

NCT ID: NCT04598542 Completed - Clinical trials for Drug-Drug Interaction

Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers

Start date: October 13, 2020
Phase: Phase 1
Study type: Interventional

This study will be an open-label, parallel-arm study to determine if a prior intra-articular (IA) injection of lorecivivint (LOR) affects the safety, tolerability, and/or pharmacokinetics (PK) of a subsequent IA injection of the corticosteroid triamcinolone acetonide (TA) into the same knee, and to determine if a prior IA injection of TA affects the safety or tolerability of a subsequent IA injection of LOR into the same knee.

NCT ID: NCT04598451 Completed - Pemphigus Vulgaris Clinical Trials

A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

ADDRESS
Start date: December 1, 2020
Phase: Phase 3
Study type: Interventional

This is a prospective, multicenter, randomized, double-blinded, placebo-controlled trial to investigate the efficacy, safety, patient outcome measures, tolerability, immunogenicity, PK, and PD of efgartigimod PH20 SC in adult participants aged from 18 years with PV or PF. The trial comprises a screening period of up to 3 weeks, a treatment period of up to 30 weeks, and an 8-week follow-up period for participants who do not enroll into the open-label extension (OLE) trial ARGX-113-1905. The primary objective of the ARGX-113-1904 trial is to demonstrate the efficacy of subcutaneous administration of efgartigimod co-formulated with recombinant human hyaluronidase PH20 (Efgartigimod PH20 SC) compared to placebo in the treatment of participants with Pemphigus Vulgaris (PV). Secondary objectives are to also demonstrate the efficacy of efgartigimod PH20 SC in the treatment of participants with Pemphigus Foliaceus (PF), and to demonstrate early onset of action and a prednisone-sparing effect. After confirmation of eligibility, participants will be randomized in a 2: 1 ratio to receive efgartigimod PH20 SC or placebo

NCT ID: NCT04598386 Completed - Cognitive Change Clinical Trials

The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration

AMPlify
Start date: December 9, 2020
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the effects of a topical sodium bicarbonate lotion on physiological and psychological responses associated with hydration status and fluid balance in humans during passive heat stress. Currently, the ingestion of sodium has been an effective measure for improvements in fluid regulation and hydration status in humans. However, the investigators do not know its regulatory relationship with measurements of fluid balance when supplemented through the skin.